References
- Mainland D. Elementary Medical Statistics2nd ed. Saunders, Philadelphia 1964
- Schor S. S. Fundamentals of Biostatistics. Putnam, New York 1968
- Zbinden G. The Problem of the Toxicologic Examination of Drugs in Animals and Their Safety in Man. Clin. Pharmacol. Therap 1964; 5: 537–545
- Koppanyi T., Avery M. A. Species Differences and the Clinical Trial of New Drugs: A Review. Clin. Pharmacol. Therap 1965; 7: 250–270
- Zbinden G. The Significance of Pharmaclogic Screening Tests in the Preclinical Safety Evaluation of New Drugs. J. New Drugs 1966; 6: 1–7
- Peck H. M. Evaluating the Safety of Drugs. BioSci 1966; 16(10)696–701
- The Staff of the Division of Pharmacology, Food and Drug Administration. Department of Health, Education, and Welfare. 1965, Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics, 2nd printing, The Association of Food and Drug Officials of the United States, Topeka, Kansas
- Goldenthal E. I. Current Views on Safety Evaluation of Drugs, FDA Papers. May, 1968; 13–18
- Burns J. J., Welch R. M., Conney A. H. Drug Effects on Enzymes. Animal and Clinical Pharmacologic Techniques in Drug Evaluation, P. E. Siegla, J. H. Moyer, III. Year Book Medical Publishers, Inc., Chicago 1967; Vol. 2: 67–75
- Brodie B. B. Physicochemical and Biochemical Aspects of Pharmacology. JAMA 1967; 202(7)148–158
- Sanen F. J., Hong E. Comparative Biotransformation of Drugs in Animal and Man. La Prensa Medica Mexicana 1969; 34: 14–18, Nos. 1 & 2
- Buyske D. A. The Metabolism of Drugs. BioSci 1966; 16: 702–705
- Wagner J. G. Biopharmaceutics Influence of Formulation on Therapeutic Activity. 1. Definitions, Scope and Relationship to Gastrointestinal Physiology. Drug Intelligence 1968; 2(2)30–34, Biopharmaceutics Influence of Formulation on Therapeutic Activity. 2. Excretion and Metabolism of Drugs, Nomenclature and Symbolism, Fundamental Principles and Concepts, Drug Intelligence 2(4), 80–85(1968); Biopharmaceutics Influence of Formulation on Therapeutic Activity. 3. The Ranking of Drugs and Several Formulations of One Drug, Drug Intelligence, 2(5), 112–117(1968); Biopharmaceutics Influence of Formulation on Therapeutic Activity. 4. Dosage of Drugs in Infants, Children and Adults, Drug Intelligence, 2(6), 144–151 (1968)
- Wagner J. G. Pharmacokinetics. 1. Definitions, Modeling and Reasons for Measuring Blood Levels and Urinary Excretion. Drug Intelligence 1968; 2(2)38–42, Pharmacokinetics. 2. The Kidney and Urinary Excretion, Drug Intelligence, 2(4), 95–99 (1968); Pharmacokinetics. 3. Half‐life and Volume of Distribution. Drug Intelligence, 2(5), 126–133 (1968); Pharmacokinetics. 4. Body Water Compartments and the Distribution of Drugs, Drug Intelligence, 2(6), 158–164 (1968)
- Riegelman S. Some Biological and Pharmacokinetic Problems in Evaluation of Dosage Forms in Animals and in Man. presented at the Research and Development Section, Pharmaceutical Manufacturers Association 20th Annual Meeting, Biloxi, Mississippi, October, 201968
- Upjohn H. L. Case Histories of How Drug Formulation Affects Clincal Drug Performance. presented at the Research and Development Section, Pharmaceutical Manufacturers Association 20th Annual Meeting, Biloxi, Mississippi, October, 201968
- Martin C. M. Comparative Physiological Availability of ‐Brand’ and ‐Generic’ Drugs in Man. Do Drugs have Religious Importpresented at the Research and Development Section, Pharmaceutical Manufacturers Association 20th Annual Meeting, Biloxi, Mississippi, October, 201968